# Acute Agitation in Emergency Psychiatry

> **NCT06752616** · PHASE2,PHASE3 · RECRUITING · sponsor: **Lone Baandrup** · enrollment: 132 (estimated)

## Conditions studied

- Agitation

## Interventions

- **DRUG:** Sublingual Dexmedetomidine
- **DRUG:** Buccal midazolam
- **DRUG:** Oral lorazepam

## Key facts

- **NCT ID:** NCT06752616
- **Lead sponsor:** Lone Baandrup
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-30
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2025-01-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06752616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06752616, "Acute Agitation in Emergency Psychiatry". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06752616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*